1. Home
  2. CXAIW vs VCEL Comparison

CXAIW vs VCEL Comparison

Compare CXAIW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CXApp Inc. Warrant

CXAIW

CXApp Inc. Warrant

HOLD

Current Price

$0.02

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$42.13

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXAIW
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
CXAIW
VCEL
Price
$0.02
$42.13
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $59.71
AVG Volume (30 Days)
17.3K
★ 481.9K
Earning Date
03-21-2025
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.00
EPS
★ N/A
N/A
Revenue
$4,583,000.00
★ $276,259,000.00
Revenue This Year
N/A
$21.71
Revenue Next Year
N/A
$16.86
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.45
52 Week Low
$0.02
$28.95
52 Week High
$2.73
$49.32

Technical Indicators

Market Signals
Indicator
CXAIW
VCEL
Relative Strength Index (RSI) 34.01 61.37
Support Level $0.03 $38.19
Resistance Level $0.27 $49.04
Average True Range (ATR) 0.00 1.42
MACD 0.01 0.31
Stochastic Oscillator 83.05 90.77

Price Performance

Historical Comparison
CXAIW
VCEL

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. Its cloud-based, mobile-first platform integrates artificial intelligence, automation, and real-time analytics to streamline workplace interactions across people, spaces, and technology. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, Agentic AI Capabilities, and CXAI-VU. The company generates the majority of its revenue from Licenses.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: